These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8361866)

  • 1. Evaluation of transdermal theophylline pharmacokinetics in neonates.
    Micali G; Bhatt RH; Distefano G; Caltabiano L; Cook B; Fischer JH; Solomon LM; West DP
    Pharmacotherapy; 1993; 13(4):386-90. PubMed ID: 8361866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery and the premature neonate.
    Barrett DA; Rutter N
    Crit Rev Ther Drug Carrier Syst; 1994; 11(1):1-30. PubMed ID: 7704917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of theophylline in neonates.
    Simons FE; Rigatto H; Simons KJ
    Semin Perinatol; 1981 Oct; 5(4):337-45. PubMed ID: 7302609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of two dosing equations for theophylline in premature infants.
    Bhatt-Mehta V; Donn SM; Schork MA; Reed S; Johnson CE
    Pharmacotherapy; 1996; 16(5):769-76. PubMed ID: 8888073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-dosage loading concentrations of theophylline and pharmacokinetic study after the fifth maintenance dosage in premature newborns with apnea].
    Rodríguez-Palomares C; Udaeta-Mora E; González-Treviño J; Juárez-Olguín H; Calderón-Mandujano B; Prado-Serrano A; Belmont-Gómez A
    Bol Med Hosp Infant Mex; 1991 Mar; 48(3):164-72. PubMed ID: 2064746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic aspects of caffeine in premature infants.
    De Carolis MP; Romagnoli C; Muzii U; Tortorolo G; Chiarotti M; De Giovanni N; Carnevale A
    Dev Pharmacol Ther; 1991; 16(3):117-22. PubMed ID: 1914785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of theophylline in preterm neonates during the first month of life.
    Islam SI; Ali AS; Sheikh AA; Fida NM
    Saudi Med J; 2004 Apr; 25(4):459-65. PubMed ID: 15083216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity.
    Jamali F; Coutts RT; Malek F; Finer NN; Peliowski A
    Dev Pharmacol Ther; 1991; 16(2):78-82. PubMed ID: 1914782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of theophylline in apnea of prematurity in small for gestational age babies.
    Chaudhuri M; Garg SK; Narang A; Bhakoo ON
    Indian Pediatr; 1996 Mar; 33(3):181-7. PubMed ID: 8772836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats.
    Ko JC; Maxwell LK; Abbo LA; Weil AB
    J Vet Pharmacol Ther; 2008 Aug; 31(4):359-67. PubMed ID: 18638297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic aspects of theophylline in premature newborns.
    Aranda JV; Sitar DS; Parsons WD; Loughnan PM; Neims AH
    N Engl J Med; 1976 Aug; 295(8):413-6. PubMed ID: 934239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting theophylline pharmacokinetics in premature infants with apnea.
    Hilligoss DM; Jusko WJ; Koup JR; Giacoia G
    Dev Pharmacol Ther; 1980; 1(1):6-15. PubMed ID: 7438966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peculiarities of the pharmacokinetics and pharmacodynamics of theophylline in children].
    Berdel D; Heimann G
    Wien Klin Wochenschr; 1984 Aug; 96(16):616-21. PubMed ID: 6516414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of an extended-release theophylline product in cats.
    Guenther-Yenke CL; McKiernan BC; Papich MG; Powell E
    J Am Vet Med Assoc; 2007 Sep; 231(6):900-6. PubMed ID: 17867974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic theophylline infusion for prevention of apnea of prematurity.
    Merchant RH; Sakhalkar VS; Ashavaid TF
    Indian Pediatr; 1992 Nov; 29(11):1359-63. PubMed ID: 1294489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline].
    Alix D; Berthou F; Riche C; Gouedard H
    Arch Fr Pediatr; 1985; 42(6):465-9. PubMed ID: 4051680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.